Search Result "primary myelofibrosis (PMF)"
Epigenetic Modifications: New Therapeutic Targets in Primary Myelofibrosis
Journal: Current Stem Cell Research & Therapy
Volume: 4 Issue: 4 Year: 2009 Page: 281-286
Author(s): Kirugaval Hemavathy, Jen C. Wang
Current and Emerging Therapies in Primary Myelofibrosis
Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 12 Issue: 1 Year: 2012 Page: 6-20
Author(s): Sabarish Ayyappan,Murali Janakiram,Radha Raghupathy
Myeloproliferative Neoplasms Including Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis, Chronic Neutrophilic Leukemia, and Myeloproliferative Neoplasm, Unclassifiable
Journal: Current Cancer Therapy Reviews
Volume: 8 Issue: 1 Year: 2012 Page: 14-29
Author(s): Robert P. Hasserjian
Philadelphia Chromosome Positive Chronic Myelogenous Leukemia BlasticCrisis in a Patient with Unusual Primary Myelofibrosis Characteristics; ACase Report
Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 22 Issue: 2 Year: 2024 Page: 240-245
Author(s):
Biology and Clinical Management of Myeloproliferative Neoplasms and Development of the JAK Inhibitor Ruxolitinib
Journal: Current Medicinal Chemistry
Volume: 19 Issue: 2 Year: 2012 Page: 4399-4413
Author(s): J. Mascarenhas, T. I. Mughal, S. Verstovsek
JAK2 Inhibitors for Myelofibrosis: Why are They Effective in Patients with and Without JAK2V617F Mutation?
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12 Issue: 9 Year: 2012 Page: 1098-1109
Author(s): Fabio P. S. Santos,Srdan Verstovsek
Current Treatment Concepts of Philadelphia-Negative MPN
Journal: Current Cancer Drug Targets
Volume: 11 Issue: 1 Year: 2011 Page: 44-55
Author(s): D. Wolf, J. Rudzki, G. Gastl
Hemopoiesis in Ph-Negative Chronic Myeloproliferative Disorders
Journal: Current Stem Cell Research & Therapy
Volume: 4 Issue: 2 Year: 2009 Page: 154-160
Author(s): Emmanouil Spanoudakis, Costas Tsatalas
Janus Kinase 2 and Transforming Growth Factor Beta Signal Transduction Targeted Therapies in BCR/ABL-Negative Myeloproliferative Neoplasms
Ebook: Frontiers in Anti-Cancer Drug Discovery
Volume: 3 Year: 2014
Author(s): Vladan P. ÄokiÄ,Juan F. Santibáñez
Doi: 10.2174/9781608058846114030004
JAK Inhibitors: Pharmacology and Clinical Activity in Chronic Myeloprolipherative Neoplasms
Journal: Current Medicinal Chemistry
Volume: 20 Issue: 9 Year: 2013 Page: 1147-1161
Author(s): J. Trelinski,T. Robak